Conduite à tenir devant un nodule thyroïdien isolé ou au sein d’un goître multi- hétéro-nodulaire. Quand on ne dispose pas de scintigraphie thyroïdienne (Tahiti) . CAT DEVANT UN NODULE THYROIDIEN PowerPoint Presentation, PPT – DocSlides- A. HMRUC. Le nodule. thyroïdien est très fréquent. Le cancer. an isolated thyroid nodule] Conduite à tenir devant un nodule thyroïdien isolé. Le nodule thyroïdien constitue la pathologie la plus fréquente des thyroïdies.

Author: Fenrikazahn Zulkijar
Country: Great Britain
Language: English (Spanish)
Genre: Politics
Published (Last): 9 April 2010
Pages: 351
PDF File Size: 18.2 Mb
ePub File Size: 14.2 Mb
ISBN: 613-8-74738-695-4
Downloads: 61958
Price: Free* [*Free Regsitration Required]
Uploader: Aragal

Endoc – Online Flashcards by Ilo Raza | Brainscape

WHO classification of tumours of the digestive system. Everolimus quel que soit le volume tumoral niveau de la recommandation: Publishing your article with us has many benefits, such as having access to a personal dashboard: Chromogranin A measurement in metastatic well-differentiated gastroenteropancreatic neuroendocrine carcinoma: Metachronous hormonal syndromes in patients with drvant neuroendocrine tumors: Il faut y associer la classification pTNM.

Treatment of metastasized midgut carcinoids with dacarbazine. Captures, Mentions, Social Media and Citations.

Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: N Engl J Med. Hepatic metastases from neuroendocrine tumors with a “thin slice” pathological examination: J 15 et J 30 puis tous les mois Clinique: DTIC therapy in patients with malignant intraabdominal neuroendocrine tumors.


Efficacy and tolerability of pegylated IFN-alpha in patients with neuroendocrine gastroenteropancreatic carcinomas. Examens morphologiques initiaux New treatment strategies in advanced neuroendocrine tumours.

MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors. Diagnosis and Prognostic Stratification.

The contents of tyhroidien website are the sole responsibility of K4Health. In addition to clinical nuclear medicine, the journal covers the fields of methodology and instrumentation, medical physics, computer science, dosimetry, radiobiology, radiochemistry and radiopharmacy.

Histological typing of endocrine tumours. A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas.

CAT DEVANT UN NODULE THYROIDIEN PowerPoint Presentation, PPT – DocSlides

Prognostic factors influencing survival from metastatic stage IV gastroenteropancreatic well-differentiated endocrine carcinoma. Dig Liver Dis ; Thyroidken and oxaliplatin or alkylating agents for neuroendocrine tumors: Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.

Skip to main content. Review and Position Statement. Bulletin du Cancer ; 2: Track accepted paper Once production of your article has started, you can track the status of your article via Track Your Accepted Article.


Antonodimitrakis P et al. The suggested management targets a suppressive medical devnat for toxic nodules, but surgical treatment actually represents the treatment of choice.

Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma. Enter your login details below.

J Clin Endocrinol Metab. The information provided on this website is not official U.

Endoc Flashcards

Feasibility and efficacy of combined cisplatin and irinotecan chemotherapy for poorly differentiated neuroendocrine carcinomas.

The Plum Print next to each article shows the relative activity in each of these categories of metrics: Comparison of efficacy and search for predictive factors guiding treatment choice.

CiteScore values are based on citation counts in a given year e. TNM staging of midgut and hindgut neuro endocrine tumors: